JP2012525431A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012525431A5 JP2012525431A5 JP2012508752A JP2012508752A JP2012525431A5 JP 2012525431 A5 JP2012525431 A5 JP 2012525431A5 JP 2012508752 A JP2012508752 A JP 2012508752A JP 2012508752 A JP2012508752 A JP 2012508752A JP 2012525431 A5 JP2012525431 A5 JP 2012525431A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- pyrido
- unsubstituted
- salt
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims description 96
- 150000003839 salts Chemical class 0.000 claims description 66
- 239000012453 solvate Substances 0.000 claims description 59
- -1 perhaloalkyl Chemical group 0.000 claims description 55
- 125000000217 alkyl group Chemical group 0.000 claims description 40
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 30
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 claims description 22
- 125000005843 halogen group Chemical group 0.000 claims description 20
- 125000001072 heteroaryl group Chemical group 0.000 claims description 20
- 125000002541 furyl group Chemical group 0.000 claims description 14
- 125000002883 imidazolyl group Chemical group 0.000 claims description 14
- 125000001715 oxadiazolyl group Chemical group 0.000 claims description 14
- 125000002971 oxazolyl group Chemical group 0.000 claims description 14
- 125000003373 pyrazinyl group Chemical group 0.000 claims description 14
- 125000004076 pyridyl group Chemical group 0.000 claims description 14
- 125000000714 pyrimidinyl group Chemical group 0.000 claims description 14
- 125000000168 pyrrolyl group Chemical group 0.000 claims description 14
- 125000001544 thienyl group Chemical group 0.000 claims description 14
- 125000003118 aryl group Chemical group 0.000 claims description 13
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 12
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 claims description 11
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 claims description 11
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 10
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 10
- 125000004442 acylamino group Chemical group 0.000 claims description 8
- 125000005102 carbonylalkoxy group Chemical group 0.000 claims description 8
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 8
- 125000003107 substituted aryl group Chemical group 0.000 claims description 8
- 239000002253 acid Substances 0.000 claims description 6
- 125000000623 heterocyclic group Chemical group 0.000 claims description 6
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 6
- 125000004215 2,4-difluorophenyl group Chemical group [H]C1=C([H])C(*)=C(F)C([H])=C1F 0.000 claims description 4
- 125000004648 C2-C8 alkenyl group Chemical group 0.000 claims description 4
- 125000004649 C2-C8 alkynyl group Chemical group 0.000 claims description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 4
- 125000002252 acyl group Chemical group 0.000 claims description 4
- 125000003545 alkoxy group Chemical group 0.000 claims description 4
- 125000000266 alpha-aminoacyl group Chemical group 0.000 claims description 4
- 150000001408 amides Chemical class 0.000 claims description 4
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 4
- 125000004104 aryloxy group Chemical group 0.000 claims description 4
- DNSISZSEWVHGLH-UHFFFAOYSA-N butanamide Chemical compound CCCC(N)=O DNSISZSEWVHGLH-UHFFFAOYSA-N 0.000 claims description 4
- 125000005589 carbonylalkylenealkoxy group Chemical group 0.000 claims description 4
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 4
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 4
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 4
- 125000004001 thioalkyl group Chemical group 0.000 claims description 4
- 150000003573 thiols Chemical class 0.000 claims description 4
- PXSYMVMGRYBTRY-UHFFFAOYSA-N 2,8-dimethyl-5-[(2-phenyl-1,3-dioxolan-2-yl)methyl]-3,4-dihydro-1h-pyrido[4,3-b]indole Chemical compound C1N(C)CCC2=C1C1=CC(C)=CC=C1N2CC1(C=2C=CC=CC=2)OCCO1 PXSYMVMGRYBTRY-UHFFFAOYSA-N 0.000 claims description 3
- KSHIBYPIOGCPDH-UHFFFAOYSA-N 2,8-dimethyl-5-[(2-pyridin-3-yl-1,3-dioxolan-2-yl)methyl]-3,4-dihydro-1h-pyrido[4,3-b]indole Chemical compound C1N(C)CCC2=C1C1=CC(C)=CC=C1N2CC1(C=2C=NC=CC=2)OCCO1 KSHIBYPIOGCPDH-UHFFFAOYSA-N 0.000 claims description 3
- WIFQQALACNYNTA-UHFFFAOYSA-N 5-[[2-(4-fluorophenyl)-1,3-dioxolan-2-yl]methyl]-2,8-dimethyl-3,4-dihydro-1h-pyrido[4,3-b]indole Chemical compound C1N(C)CCC2=C1C1=CC(C)=CC=C1N2CC1(C=2C=CC(F)=CC=2)OCCO1 WIFQQALACNYNTA-UHFFFAOYSA-N 0.000 claims description 3
- NXUKGYHIRFZZSE-UHFFFAOYSA-N 8-chloro-2-methyl-5-[[2-(2-methylpyridin-4-yl)-1,3-dioxolan-2-yl]methyl]-3,4-dihydro-1h-pyrido[4,3-b]indole Chemical compound C1N(C)CCC2=C1C1=CC(Cl)=CC=C1N2CC1(C=2C=C(C)N=CC=2)OCCO1 NXUKGYHIRFZZSE-UHFFFAOYSA-N 0.000 claims description 3
- XNSPQXHRNZQWTD-UHFFFAOYSA-N 8-chloro-2-methyl-5-[[2-(6-methylpyridin-3-yl)-1,3-dioxolan-2-yl]methyl]-3,4-dihydro-1h-pyrido[4,3-b]indole Chemical compound C1N(C)CCC2=C1C1=CC(Cl)=CC=C1N2CC1(C=2C=NC(C)=CC=2)OCCO1 XNSPQXHRNZQWTD-UHFFFAOYSA-N 0.000 claims description 3
- VAVLJFSBBMYFKS-UHFFFAOYSA-N 8-chloro-5-[[2-(4-chlorophenyl)-1,3-dioxolan-2-yl]methyl]-2-methyl-3,4-dihydro-1h-pyrido[4,3-b]indole Chemical compound C1N(C)CCC2=C1C1=CC(Cl)=CC=C1N2CC1(C=2C=CC(Cl)=CC=2)OCCO1 VAVLJFSBBMYFKS-UHFFFAOYSA-N 0.000 claims description 3
- 239000003937 drug carrier Substances 0.000 claims description 3
- 239000008194 pharmaceutical composition Substances 0.000 claims description 3
- CEHPIEPEGHHJJZ-UHFFFAOYSA-N 2,8-dimethyl-5-[(2-pyrimidin-4-yl-1,3-dioxolan-2-yl)methyl]-3,4-dihydro-1h-pyrido[4,3-b]indole Chemical compound C1N(C)CCC2=C1C1=CC(C)=CC=C1N2CC1(C=2N=CN=CC=2)OCCO1 CEHPIEPEGHHJJZ-UHFFFAOYSA-N 0.000 claims description 2
- SDDGVYKUUGHLJD-UHFFFAOYSA-N 2-(2,8-dimethyl-3,4-dihydro-1h-pyrido[4,3-b]indol-5-yl)-1-(4-fluorophenyl)-1-phenylethanol Chemical compound C1N(C)CCC2=C1C1=CC(C)=CC=C1N2CC(O)(C=1C=CC(F)=CC=1)C1=CC=CC=C1 SDDGVYKUUGHLJD-UHFFFAOYSA-N 0.000 claims description 2
- UBFWYALTTULUDG-UHFFFAOYSA-N 2-cyclopropyl-5-[2-fluoro-2-(4-methoxyphenyl)propyl]-8-methyl-3,4-dihydro-1h-pyrido[4,3-b]indole Chemical compound C1=CC(OC)=CC=C1C(C)(F)CN1C2=CC=C(C)C=C2C2=C1CCN(C1CC1)C2 UBFWYALTTULUDG-UHFFFAOYSA-N 0.000 claims description 2
- YYBJLIFFKRGEED-UHFFFAOYSA-N 2-ethyl-5-(2-fluoro-2-pyridin-3-ylpropyl)-8-methyl-3,4-dihydro-1h-pyrido[4,3-b]indole Chemical compound C1N(CC)CCC2=C1C1=CC(C)=CC=C1N2CC(C)(F)C1=CC=CN=C1 YYBJLIFFKRGEED-UHFFFAOYSA-N 0.000 claims description 2
- CRBBHOGWBDLVRA-UHFFFAOYSA-N 2-methyl-5-[(2-pyridin-4-yl-1,3-dioxolan-2-yl)methyl]-3,4-dihydro-1h-pyrido[4,3-b]indole Chemical compound C1N(C)CCC2=C1C1=CC=CC=C1N2CC1(C=2C=CN=CC=2)OCCO1 CRBBHOGWBDLVRA-UHFFFAOYSA-N 0.000 claims description 2
- QXTAYFISWQSPRT-UHFFFAOYSA-N 3-(2,4-difluorophenyl)-4-(2,8-dimethyl-3,4-dihydro-1h-pyrido[4,3-b]indol-5-yl)butanoic acid Chemical compound C1N(C)CCC2=C1C1=CC(C)=CC=C1N2CC(CC(O)=O)C1=CC=C(F)C=C1F QXTAYFISWQSPRT-UHFFFAOYSA-N 0.000 claims description 2
- WXTVXXFBPXVBTO-UHFFFAOYSA-N 4-(2,8-dimethyl-3,4-dihydro-1h-pyrido[4,3-b]indol-5-yl)-3-(2-fluorophenyl)-n-methylbutanamide Chemical compound C1=2CCN(C)CC=2C2=CC(C)=CC=C2N1CC(CC(=O)NC)C1=CC=CC=C1F WXTVXXFBPXVBTO-UHFFFAOYSA-N 0.000 claims description 2
- OPMKRVRPBZAAMY-UHFFFAOYSA-N 4-(2,8-dimethyl-3,4-dihydro-1h-pyrido[4,3-b]indol-5-yl)-3-(2-fluorophenyl)butanoic acid Chemical compound C1N(C)CCC2=C1C1=CC(C)=CC=C1N2CC(CC(O)=O)C1=CC=CC=C1F OPMKRVRPBZAAMY-UHFFFAOYSA-N 0.000 claims description 2
- CMBIIHJHLILBSO-UHFFFAOYSA-N 4-(2,8-dimethyl-3,4-dihydro-1h-pyrido[4,3-b]indol-5-yl)-3-(4-fluorophenyl)-n-methylbutanamide Chemical compound C1=2CCN(C)CC=2C2=CC(C)=CC=C2N1CC(CC(=O)NC)C1=CC=C(F)C=C1 CMBIIHJHLILBSO-UHFFFAOYSA-N 0.000 claims description 2
- WPRCVURQRSQRDQ-UHFFFAOYSA-N 4-(2,8-dimethyl-3,4-dihydro-1h-pyrido[4,3-b]indol-5-yl)-3-(4-fluorophenyl)butanoic acid Chemical compound C1N(C)CCC2=C1C1=CC(C)=CC=C1N2CC(CC(O)=O)C1=CC=C(F)C=C1 WPRCVURQRSQRDQ-UHFFFAOYSA-N 0.000 claims description 2
- NLHAWMARHNLPJU-UHFFFAOYSA-N 4-(2,8-dimethyl-3,4-dihydro-1h-pyrido[4,3-b]indol-5-yl)-3-pyridin-3-ylbutanoic acid Chemical compound C1N(C)CCC2=C1C1=CC(C)=CC=C1N2CC(CC(O)=O)C1=CC=CN=C1 NLHAWMARHNLPJU-UHFFFAOYSA-N 0.000 claims description 2
- GFXZZEBQRNFDPE-UHFFFAOYSA-N 4-(8-chloro-2-methyl-3,4-dihydro-1h-pyrido[4,3-b]indol-5-yl)-3-(4-chlorophenyl)-n-methylbutanamide Chemical compound C1=2CCN(C)CC=2C2=CC(Cl)=CC=C2N1CC(CC(=O)NC)C1=CC=C(Cl)C=C1 GFXZZEBQRNFDPE-UHFFFAOYSA-N 0.000 claims description 2
- HFYNOYFHGWDKRQ-UHFFFAOYSA-N 4-(8-chloro-2-methyl-3,4-dihydro-1h-pyrido[4,3-b]indol-5-yl)-3-(4-chlorophenyl)butanoic acid Chemical compound C1N(C)CCC2=C1C1=CC(Cl)=CC=C1N2CC(CC(O)=O)C1=CC=C(Cl)C=C1 HFYNOYFHGWDKRQ-UHFFFAOYSA-N 0.000 claims description 2
- QNTGEWKKHKULDO-UHFFFAOYSA-N 4-(8-chloro-2-methyl-3,4-dihydro-1h-pyrido[4,3-b]indol-5-yl)-3-(4-methoxyphenyl)butanoic acid Chemical compound C1=CC(OC)=CC=C1C(CC(O)=O)CN1C2=CC=C(Cl)C=C2C2=C1CCN(C)C2 QNTGEWKKHKULDO-UHFFFAOYSA-N 0.000 claims description 2
- ZHAOCYAINPJTBG-UHFFFAOYSA-N 4-(8-chloro-2-methyl-3,4-dihydro-1h-pyrido[4,3-b]indol-5-yl)-3-pyrimidin-4-ylbutanoic acid Chemical compound C1N(C)CCC2=C1C1=CC(Cl)=CC=C1N2CC(CC(O)=O)C1=CC=NC=N1 ZHAOCYAINPJTBG-UHFFFAOYSA-N 0.000 claims description 2
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 claims description 2
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 claims description 2
- JHTDVHAJMMAAIW-UHFFFAOYSA-N 5-(2-fluoro-2-pyridin-4-ylpropyl)-2,8-dimethyl-3,4-dihydro-1h-pyrido[4,3-b]indole Chemical compound C1N(C)CCC2=C1C1=CC(C)=CC=C1N2CC(C)(F)C1=CC=NC=C1 JHTDVHAJMMAAIW-UHFFFAOYSA-N 0.000 claims description 2
- GOVOMCQLELOXOH-UHFFFAOYSA-N 5-(2-fluoro-2-pyrimidin-4-ylpropyl)-2,8-dimethyl-3,4-dihydro-1h-pyrido[4,3-b]indole Chemical compound C1N(C)CCC2=C1C1=CC(C)=CC=C1N2CC(C)(F)C1=CC=NC=N1 GOVOMCQLELOXOH-UHFFFAOYSA-N 0.000 claims description 2
- YQQMLLFAAOPODD-UHFFFAOYSA-N 5-[2-(4-chlorophenyl)-2-fluoropropyl]-2,8-dimethyl-3,4-dihydro-1h-pyrido[4,3-b]indole Chemical compound C1N(C)CCC2=C1C1=CC(C)=CC=C1N2CC(C)(F)C1=CC=C(Cl)C=C1 YQQMLLFAAOPODD-UHFFFAOYSA-N 0.000 claims description 2
- MCXPOPAHXQJKEF-UHFFFAOYSA-N 5-[2-fluoro-2-(2-methylpyridin-4-yl)propyl]-2,8-dimethyl-3,4-dihydro-1h-pyrido[4,3-b]indole Chemical compound C1N(C)CCC2=C1C1=CC(C)=CC=C1N2CC(C)(F)C1=CC=NC(C)=C1 MCXPOPAHXQJKEF-UHFFFAOYSA-N 0.000 claims description 2
- RKPPXNINQHFRTD-UHFFFAOYSA-N 5-[2-fluoro-2-(4-fluorophenyl)propyl]-2,8-dimethyl-3,4-dihydro-1h-pyrido[4,3-b]indole Chemical compound C1N(C)CCC2=C1C1=CC(C)=CC=C1N2CC(C)(F)C1=CC=C(F)C=C1 RKPPXNINQHFRTD-UHFFFAOYSA-N 0.000 claims description 2
- WDTMBTSDKCPDBW-UHFFFAOYSA-N 8-chloro-2-methyl-5-[2-(3-methylpyridin-4-yl)butyl]-3,4-dihydro-1H-pyrido[4,3-b]indole Chemical compound CCC(CN1C2=C(CN(C)CC2)C2=CC(Cl)=CC=C12)C1=C(C)C=NC=C1 WDTMBTSDKCPDBW-UHFFFAOYSA-N 0.000 claims description 2
- FQGQMNNNLBPFDH-UHFFFAOYSA-N 8-chloro-2-methyl-5-[[2-(3-methylpyridin-4-yl)-1,3-dioxolan-2-yl]methyl]-3,4-dihydro-1h-pyrido[4,3-b]indole Chemical compound C1N(C)CCC2=C1C1=CC(Cl)=CC=C1N2CC1(C=2C(=CN=CC=2)C)OCCO1 FQGQMNNNLBPFDH-UHFFFAOYSA-N 0.000 claims description 2
- ARAICNLSMVFMIA-UHFFFAOYSA-N 8-chloro-5-(2-fluoro-2-pyridin-3-ylpropyl)-2-methyl-3,4-dihydro-1h-pyrido[4,3-b]indole Chemical compound C1N(C)CCC2=C1C1=CC(Cl)=CC=C1N2CC(C)(F)C1=CC=CN=C1 ARAICNLSMVFMIA-UHFFFAOYSA-N 0.000 claims description 2
- DVDZIMYMWCQZOA-UHFFFAOYSA-N 8-chloro-5-(2-fluoro-2-pyridin-4-ylpropyl)-2-methyl-3,4-dihydro-1h-pyrido[4,3-b]indole Chemical compound C1N(C)CCC2=C1C1=CC(Cl)=CC=C1N2CC(C)(F)C1=CC=NC=C1 DVDZIMYMWCQZOA-UHFFFAOYSA-N 0.000 claims description 2
- ZVDZIWOYYUERJP-UHFFFAOYSA-N 8-chloro-5-[2-(2,4-difluorophenyl)-2-fluoropropyl]-2-methyl-3,4-dihydro-1h-pyrido[4,3-b]indole Chemical compound C1N(C)CCC2=C1C1=CC(Cl)=CC=C1N2CC(C)(F)C1=CC=C(F)C=C1F ZVDZIWOYYUERJP-UHFFFAOYSA-N 0.000 claims description 2
- ZYCJYYFQJHKNMC-UHFFFAOYSA-N 8-chloro-5-[2-fluoro-2-(6-methylpyridin-3-yl)propyl]-2-methyl-3,4-dihydro-1h-pyrido[4,3-b]indole Chemical compound C1N(C)CCC2=C1C1=CC(Cl)=CC=C1N2CC(C)(F)C1=CC=C(C)N=C1 ZYCJYYFQJHKNMC-UHFFFAOYSA-N 0.000 claims description 2
- VPCVVOOGNDRGFN-UHFFFAOYSA-N 8-chloro-5-[[2-(2-chlorophenyl)-1,3-dioxolan-2-yl]methyl]-2-methyl-3,4-dihydro-1h-pyrido[4,3-b]indole Chemical compound C1N(C)CCC2=C1C1=CC(Cl)=CC=C1N2CC1(C=2C(=CC=CC=2)Cl)OCCO1 VPCVVOOGNDRGFN-UHFFFAOYSA-N 0.000 claims description 2
- MQTGBDFTUKTJSY-UHFFFAOYSA-N CCC(CN1C2=C(CN(CC2)C)C3=C1C=CC(=C3)Cl)C4=CN=C(C=C4)C Chemical compound CCC(CN1C2=C(CN(CC2)C)C3=C1C=CC(=C3)Cl)C4=CN=C(C=C4)C MQTGBDFTUKTJSY-UHFFFAOYSA-N 0.000 claims description 2
- DQBINRGWLUXRHX-UHFFFAOYSA-N CCC(CN1C2=C(CN(CC2)CC)C3=C1C=CC(=C3)C)C4=CC(=NC=C4)C Chemical compound CCC(CN1C2=C(CN(CC2)CC)C3=C1C=CC(=C3)C)C4=CC(=NC=C4)C DQBINRGWLUXRHX-UHFFFAOYSA-N 0.000 claims description 2
- 102000000543 Histamine Receptors Human genes 0.000 claims description 2
- 108010002059 Histamine Receptors Proteins 0.000 claims description 2
- 125000004423 acyloxy group Chemical group 0.000 claims description 2
- 125000004656 alkyl sulfonylamino group Chemical group 0.000 claims description 2
- 230000019771 cognition Effects 0.000 claims description 2
- 208000010877 cognitive disease Diseases 0.000 claims description 2
- 125000004122 cyclic group Chemical group 0.000 claims description 2
- 125000000392 cycloalkenyl group Chemical group 0.000 claims description 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 2
- NCKQTYFVEMJDIE-UHFFFAOYSA-N ethyl 4-(2,8-dimethyl-3,4-dihydro-1h-pyrido[4,3-b]indol-5-yl)-3-(4-fluorophenyl)butanoate Chemical compound C1=2CCN(C)CC=2C2=CC(C)=CC=C2N1CC(CC(=O)OCC)C1=CC=C(F)C=C1 NCKQTYFVEMJDIE-UHFFFAOYSA-N 0.000 claims description 2
- 208000024891 symptom Diseases 0.000 claims description 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims 4
- OUNFKARXQGDBIP-UHFFFAOYSA-N 4-(2,8-dimethyl-3,4-dihydro-1h-pyrido[4,3-b]indol-5-yl)-3-pyridin-4-ylbutanoic acid Chemical compound C1N(C)CCC2=C1C1=CC(C)=CC=C1N2CC(CC(O)=O)C1=CC=NC=C1 OUNFKARXQGDBIP-UHFFFAOYSA-N 0.000 claims 1
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 0 *C(*)(*)C[n]1c2ccc(*)cc2c2c1CCN(*)C2 Chemical compound *C(*)(*)C[n]1c2ccc(*)cc2c2c1CCN(*)C2 0.000 description 19
- NXUDRZAGTICPOO-UHFFFAOYSA-N 5-(2-fluoro-2-pyridin-4-ylethyl)-2,8-dimethyl-3,4-dihydro-1h-pyrido[4,3-b]indole Chemical compound C1N(C)CCC2=C1C1=CC(C)=CC=C1N2CC(F)C1=CC=NC=C1 NXUDRZAGTICPOO-UHFFFAOYSA-N 0.000 description 1
- QSWKMJOKNSYKKR-UHFFFAOYSA-N 8-chloro-5-[2-fluoro-2-(3-methylpyridin-4-yl)propyl]-2-propan-2-yl-3,4-dihydro-1h-pyrido[4,3-b]indole Chemical compound C1N(C(C)C)CCC2=C1C1=CC(Cl)=CC=C1N2CC(C)(F)C1=CC=NC=C1C QSWKMJOKNSYKKR-UHFFFAOYSA-N 0.000 description 1
- 208000028698 Cognitive impairment Diseases 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1135/NUM/2009 | 2009-04-29 | ||
| IN1135MU2009 | 2009-04-29 | ||
| US18125909P | 2009-05-26 | 2009-05-26 | |
| US61/181,259 | 2009-05-26 | ||
| PCT/US2010/033055 WO2011019417A1 (en) | 2009-04-29 | 2010-04-29 | Pyrido [4, 3-b] indoles and methods of use |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012525431A JP2012525431A (ja) | 2012-10-22 |
| JP2012525431A5 true JP2012525431A5 (enExample) | 2013-06-27 |
| JP5827943B2 JP5827943B2 (ja) | 2015-12-02 |
Family
ID=43586371
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012508752A Expired - Fee Related JP5827943B2 (ja) | 2009-04-29 | 2010-04-29 | ピリド［４，３−ｂ］インドールおよびその使用方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US8741919B2 (enExample) |
| EP (1) | EP2424366B1 (enExample) |
| JP (1) | JP5827943B2 (enExample) |
| CN (1) | CN102480956B (enExample) |
| AU (1) | AU2010282990B2 (enExample) |
| BR (1) | BRPI1006608A2 (enExample) |
| CA (1) | CA2760516A1 (enExample) |
| WO (1) | WO2011019417A1 (enExample) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2007139634A (ru) | 2007-10-25 | 2009-04-27 | Сергей Олегович Бачурин (RU) | Новые тиазол-, триазол- или оксадиазол-содержащие тетрациклические соединения |
| RU2544856C2 (ru) * | 2008-01-25 | 2015-03-20 | Сергей Олегович Бачурин | НОВЫЕ ПРОИЗВОДНЫЕ 2,3,4,5-ТЕТРАГИДРО-1-ПИРИДО[4,3-b]ИНДОЛА И СПОСОБЫ ИХ ПРИМЕНЕНИЯ |
| TWI443098B (zh) | 2008-03-24 | 2014-07-01 | Medivation Technologies Inc | 吡啶并〔３，４－ｂ〕吲哚及使用方法 |
| TWI450900B (zh) | 2008-03-24 | 2014-09-01 | Medivation Technologies Inc | 橋聯雜環化合物及使用方法 |
| AR073923A1 (es) | 2008-10-31 | 2010-12-09 | Medivation Technologies Inc | Pirido( 4,3-b) indoles que contienen restos rigidos |
| CN102316732B (zh) | 2008-10-31 | 2015-04-01 | 梅迪维新技术公司 | 氮杂*并[4,5-b]吲哚以及使用方法 |
| US9162980B2 (en) | 2009-01-09 | 2015-10-20 | Board Of Regents Of The University Of Texas System | Anti-depression compounds |
| US9095572B2 (en) * | 2009-01-09 | 2015-08-04 | Board Of Regents Of The University Of Texas System | Pro-neurogenic compounds |
| US8362277B2 (en) | 2009-01-09 | 2013-01-29 | Board Of Regents Of The University Of Texas System | Pro-neurogenic compounds |
| US9962368B2 (en) | 2009-01-09 | 2018-05-08 | Board Of Regents Of The University Of Texas System | Pro-neurogenic compounds |
| CA2748813C (en) | 2009-01-09 | 2018-07-10 | Board Of Regents Of The University Of Texas System | Pro-neurogenic compounds |
| AU2010214101A1 (en) | 2009-02-11 | 2011-09-01 | Sunovion Pharmaceuticals Inc. | Histamine H3 inverse agonists and antagonists and methods of use thereof |
| WO2010127177A1 (en) * | 2009-04-29 | 2010-11-04 | Medivation Technologies, Inc. | Pyrido [4,3-b] indoles and methods of use |
| WO2011019417A1 (en) | 2009-04-29 | 2011-02-17 | Medivation Technologies, Inc. | Pyrido [4, 3-b] indoles and methods of use |
| WO2011038161A1 (en) | 2009-09-23 | 2011-03-31 | Medivation Technologies, Inc. | Pyrido[4,3-b]indoles and methods of use |
| CN102711466A (zh) | 2009-09-23 | 2012-10-03 | 梅迪维新技术公司 | 桥连杂环化合物及其使用方法 |
| AU2010298168B2 (en) | 2009-09-23 | 2015-11-19 | Medivation Technologies, Inc. | Pyrido(3,4-b)indoles and methods of use |
| US9040519B2 (en) | 2010-02-18 | 2015-05-26 | Medivation Technologies, Inc. | Fused tetracyclic pyrido [4,3-B] indole and pyrido [3,4-B] indole derivatives and methods of use |
| US9193728B2 (en) | 2010-02-18 | 2015-11-24 | Medivation Technologies, Inc. | Fused tetracyclic pyrido [4,3-B] indole and pyrido [3,4-B] indole derivatives and methods of use |
| US9034865B2 (en) | 2010-02-18 | 2015-05-19 | Medivation Technologies, Inc. | Pyrido [4,3-B] indole and pyrido [3,4-B] indole derivatives and methods of use |
| US9187471B2 (en) | 2010-02-19 | 2015-11-17 | Medivation Technologies, Inc. | Pyrido [4,3-b] indole and pyrido [3,4-b] indole derivatives and methods of use |
| WO2012112964A2 (en) | 2011-02-18 | 2012-08-23 | Medivation Technologies, Inc. | PYRIDO[4,3-b]INDOLE AND PYRIDO[3,4-b]INDOLE DERIVATIVES AND METHODS OF USE |
| US20140155384A1 (en) | 2011-02-18 | 2014-06-05 | Medivation Technologies, Inc. | Compounds and methods of treating diabetes |
| WO2012112965A1 (en) | 2011-02-18 | 2012-08-23 | Medivation Technologies, Inc. | Compounds and methods of treating diabetes |
| CA2829045A1 (en) | 2011-02-18 | 2012-08-23 | Medivation Technologies, Inc. | Compounds and methods for treatment of hypertension |
| EP2785720B1 (en) * | 2011-11-29 | 2017-08-09 | Nanjing Allgen Pharma Co. Ltd. | Heterocyclic amides compounds which are hdac6 inhibitors and used as anti-tumoral agents |
| WO2014031167A1 (en) * | 2012-08-22 | 2014-02-27 | Medivation Technologies, Inc. | Compounds and methods for treatment of hypertension |
| EP2887803A4 (en) | 2012-08-24 | 2016-08-03 | Univ Texas | PRO-NEUROGENIC COMPOUNDS |
| WO2015070237A1 (en) | 2013-11-11 | 2015-05-14 | Board Of Regents Of The University Of Texas System | Neuroprotective chemicals and methods for identifying and using same |
| EP3068388A4 (en) | 2013-11-11 | 2017-04-12 | Board of Regents of the University of Texas System | Neuroprotective compounds and use thereof |
| MX2020008237A (es) | 2018-02-05 | 2020-09-25 | Univ Rockefeller | Inhibidores de 2,3,4,5-tetrahidro-1h-pirido[4,3-b]indol de cgas para tratar enfermedades autoinflamatorias. |
| EP4216940A4 (en) * | 2020-09-24 | 2025-01-01 | Ventus Therapeutics U.S., Inc. | PYRIDO[4,3-B INDOLE DERIVATIVES AND THEIR USE AS MEDICAMENTS |
Family Cites Families (60)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3409628A (en) | 1966-05-12 | 1968-11-05 | Hoffmann La Roche | 5-(3-pyridylethyl)pyridoindole derivatives |
| US3484449A (en) | 1966-05-12 | 1969-12-16 | Hoffmann La Roche | Certain substituted phenyl amino-ethylpyridine intermediates |
| US3502688A (en) | 1968-09-10 | 1970-03-24 | Hoffmann La Roche | 5-(4-pyridylethyl)-pyridoindole derivatives |
| US3646045A (en) | 1968-09-10 | 1972-02-29 | Hoffmann La Roche | Intermediates for 5-(4-pyridylethyl)-pyridoindole derivatives |
| JPS5143863B2 (enExample) | 1973-06-18 | 1976-11-25 | ||
| US4754038A (en) | 1987-02-26 | 1988-06-28 | American Home Products Corporation | Carboline histamine H1 antagonists |
| IL91167A (en) | 1988-08-02 | 1993-06-10 | Glaxo Group Ltd | Substituted 2-(imidazolymethyl)-pyrido- (and azepino-) indol-1-one derivatives, their preparation and pharmaceutical compositions containing them |
| RU2140417C1 (ru) | 1995-10-17 | 1999-10-27 | Институт физиологически активных веществ РАН | Производные гидрированных пиридо(4,3-b)индолов, способы их получения, фармацевтическая композиция и способ лечения |
| RU2106864C1 (ru) | 1995-10-23 | 1998-03-20 | Николай Серафимович Зефиров | Средство для лечения болезни альцгеймера |
| DE10030375A1 (de) | 2000-06-21 | 2002-01-03 | Bayer Ag | Verwendung von MTP-Inhibitoren zur Senkung von ppTRL |
| US6849640B2 (en) | 2001-08-08 | 2005-02-01 | Pharmacia & Upjohn Company | Therapeutic 1H-pyrido [4,3-b] indoles |
| US7736889B2 (en) | 2003-06-10 | 2010-06-15 | The United States Of America As Represented By The Secretary Of The Navy | Fluidic force discrimination |
| PL1831227T3 (pl) | 2004-12-17 | 2013-10-31 | Glenmark Pharmaceuticals Sa | Nowe związki heterocykliczne użyteczne w leczeniu stanów zapalnych i dolegliwości alergicznych |
| MX2008000811A (es) * | 2005-07-28 | 2008-03-18 | Squibb Bristol Myers Co | Tetrahidro-1h-pitido[4,3-b]indoles substituidos como agonistas y antagonistas del receptor de serotonina. |
| WO2007041697A2 (en) | 2005-10-04 | 2007-04-12 | Medivation, Inc. | Hydrogenated pyrido-indole compounds for the treatment of huntington ' s disease |
| RU2338537C2 (ru) * | 2006-01-25 | 2008-11-20 | Сергей Олегович Бачурин | СРЕДСТВО ДЛЯ ЛЕЧЕНИЯ ШИЗОФРЕНИИ НА ОСНОВЕ ГИДРИРОВАННЫХ ПИРИДО(4,3-b)ИНДОЛОВ (ВАРИАНТЫ), ФАРМАКОЛОГИЧЕСКОЕ СРЕДСТВО НА ЕГО ОСНОВЕ И СПОСОБ ЕГО ПРИМЕНЕНИЯ |
| US20100099700A1 (en) | 2006-09-20 | 2010-04-22 | David Hung | Hydrogenated pyrido (4,3-b) indoles for treating amyotrophic lateral sclerosis (als) |
| CA2664098A1 (en) | 2006-09-20 | 2008-03-27 | Medivation Neurology, Inc. | Compounds and method for treating canine cognitive dysfunction syndrome |
| EP2420235A1 (en) | 2006-10-27 | 2012-02-22 | Medivation Neurology, Inc. | Methods and combination therapies for treating alzheimer's disease |
| RU2329044C1 (ru) | 2006-11-16 | 2008-07-20 | Андрей Александрович Иващенко | Лиганды 5-ht6 рецепторов, фармацевтическая композиция, способ ее получения и лекарственное средство |
| RU2334514C1 (ru) | 2006-12-01 | 2008-09-27 | Институт физиологически активных веществ Российской Академии наук | СРЕДСТВО ДЛЯ УЛУЧШЕНИЯ КОГНИТИВНЫХ ФУНКЦИЙ И ПАМЯТИ НА ОСНОВЕ ГИДРИРОВАННЫХ ПИРИДО (4,3-b) ИНДОЛОВ (ВАРИАНТЫ), ФАРМАКОЛОГИЧЕСКОЕ СРЕДСТВО НА ЕГО ОСНОВЕ И СПОСОБ ЕГО ПРИМЕНЕНИЯ |
| RU2340342C2 (ru) | 2006-12-07 | 2008-12-10 | Сергей Олегович Бачурин | СРЕДСТВО ДЛЯ ЛЕЧЕНИЯ ОСТРЫХ И ХРОНИЧЕСКИХ НАРУШЕНИЙ МОЗГОВОГО КРОВООБРАЩЕНИЯ, В ТОМ ЧИСЛЕ ИНСУЛЬТА, НА ОСНОВЕ ГИДРИРОВАННЫХ ПИРИДО[4,3-b]ИНДОЛОВ (ВАРИАНТЫ), ФАРМАКОЛОГИЧЕСКОЕ СРЕДСТВО НА ЕГО ОСНОВЕ И СПОСОБ ЕГО ПРИМЕНЕНИЯ |
| RU2338745C1 (ru) | 2007-03-21 | 2008-11-20 | Андрей Александрович Иващенко | ЗАМЕЩЕННЫЕ 2,3,4,5-ТЕТРАГИДРО-1Н-ПИРИДО[4,3-b]ИНДОЛЫ, СПОСОБЫ ИХ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЯ |
| RU2339637C1 (ru) | 2007-04-05 | 2008-11-27 | Андрей Александрович Иващенко | Блокаторы гистаминного рецептора для фармацевтических композиций, обладающих противоаллергическим и аутоиммунным действием |
| US8541437B2 (en) | 2007-04-05 | 2013-09-24 | Alla Chem, Llc | Substituted 2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indoles, methods for the production and use thereof |
| MX2009012788A (es) | 2007-05-25 | 2010-01-14 | Medivation Neurology Inc | Metodos y composiciones para estimular celulas. |
| RU2338533C1 (ru) | 2007-06-28 | 2008-11-20 | Сергей Олегович Бачурин | СРЕДСТВО, ОБЛАДАЮЩЕЕ АНКСИОЛИТИЧЕСКИМ ДЕЙСТВИЕМ, НА ОСНОВЕ ГИДРИРОВАННЫХ ПИРИДО(4,3-b)ИНДОЛОВ (ВАРИАНТЫ), ФАРМАКОЛОГИЧЕСКОЕ СРЕДСТВО НА ЕГО ОСНОВЕ И СПОСОБ ЕГО ПРИМЕНЕНИЯ |
| CA2719824A1 (en) | 2007-08-01 | 2009-02-05 | Medivation Neurology, Inc. | Methods and compositions for treating schizophrenia using antipsychotic combination therapy |
| AU2008302751A1 (en) | 2007-09-20 | 2009-03-26 | D2E, Llc | Fluoro-containing derivatives of hydrogenated pyrido[4,3-b]indoles with neuroprotective and cognition enhancing properties, process for preparing, and use |
| WO2009039420A1 (en) | 2007-09-21 | 2009-03-26 | Medivation Neurology, Inc. | Methods and compositions for treating neuronal death mediated ocular diseases |
| RU2007139634A (ru) | 2007-10-25 | 2009-04-27 | Сергей Олегович Бачурин (RU) | Новые тиазол-, триазол- или оксадиазол-содержащие тетрациклические соединения |
| EP2236511A4 (en) | 2007-12-21 | 2011-04-13 | Alla Chem Llc | LIGANDS OF ALPHA ADRENOCEPTORS AND OF DOPAMINE, HISTAMIN, IMIDAZOLIN AND SEROTONIN RECEPTORS AND THEIR APPLICATION THEREOF |
| RU2544856C2 (ru) | 2008-01-25 | 2015-03-20 | Сергей Олегович Бачурин | НОВЫЕ ПРОИЗВОДНЫЕ 2,3,4,5-ТЕТРАГИДРО-1-ПИРИДО[4,3-b]ИНДОЛА И СПОСОБЫ ИХ ПРИМЕНЕНИЯ |
| WO2009111540A1 (en) | 2008-03-04 | 2009-09-11 | Medivation Neurology, Inc. | Methods for preparing pyridylethyl-substituted carbolines |
| TWI443098B (zh) | 2008-03-24 | 2014-07-01 | Medivation Technologies Inc | 吡啶并〔３，４－ｂ〕吲哚及使用方法 |
| TWI450900B (zh) | 2008-03-24 | 2014-09-01 | Medivation Technologies Inc | 橋聯雜環化合物及使用方法 |
| WO2009135091A1 (en) | 2008-04-30 | 2009-11-05 | Medivation Technologies, Inc. | Use of asenapine and related compounds for the treatment of neuronal or non-neuronal diseases or conditions |
| CN101640878B (zh) | 2008-07-29 | 2011-08-31 | 华为技术有限公司 | 一种确定漫游用户终端移动性的方法及装置 |
| WO2010014758A1 (en) | 2008-07-30 | 2010-02-04 | Edison Pharmaceuticals, Inc. | Use of hydrogenated pyrido[4,3-b] indoles for the treatment of oxidative stress |
| CN102316732B (zh) | 2008-10-31 | 2015-04-01 | 梅迪维新技术公司 | 氮杂*并[4,5-b]吲哚以及使用方法 |
| AR073923A1 (es) * | 2008-10-31 | 2010-12-09 | Medivation Technologies Inc | Pirido( 4,3-b) indoles que contienen restos rigidos |
| WO2011019417A1 (en) | 2009-04-29 | 2011-02-17 | Medivation Technologies, Inc. | Pyrido [4, 3-b] indoles and methods of use |
| WO2010127177A1 (en) * | 2009-04-29 | 2010-11-04 | Medivation Technologies, Inc. | Pyrido [4,3-b] indoles and methods of use |
| WO2011014695A1 (en) | 2009-07-29 | 2011-02-03 | Medivation Technologies, Inc. | New 2,3,4,5-tetrahydro-1h-pyrido[4,3-b] indoles and methods of use |
| EP2480079A4 (en) | 2009-09-23 | 2015-04-08 | Medivation Technologies Inc | PYRIDO- (3,4-B-) INDOLE AND USE METHOD THEREFOR |
| WO2011038161A1 (en) | 2009-09-23 | 2011-03-31 | Medivation Technologies, Inc. | Pyrido[4,3-b]indoles and methods of use |
| CN102711466A (zh) | 2009-09-23 | 2012-10-03 | 梅迪维新技术公司 | 桥连杂环化合物及其使用方法 |
| AU2010298168B2 (en) | 2009-09-23 | 2015-11-19 | Medivation Technologies, Inc. | Pyrido(3,4-b)indoles and methods of use |
| US9040519B2 (en) | 2010-02-18 | 2015-05-26 | Medivation Technologies, Inc. | Fused tetracyclic pyrido [4,3-B] indole and pyrido [3,4-B] indole derivatives and methods of use |
| WO2011103487A1 (en) | 2010-02-18 | 2011-08-25 | Medivation Technologies, Inc. | Pyrido[4,3-b]indole and pyrido[3,4-b]indole derivatives and methods of use |
| US9193728B2 (en) | 2010-02-18 | 2015-11-24 | Medivation Technologies, Inc. | Fused tetracyclic pyrido [4,3-B] indole and pyrido [3,4-B] indole derivatives and methods of use |
| US9034865B2 (en) | 2010-02-18 | 2015-05-19 | Medivation Technologies, Inc. | Pyrido [4,3-B] indole and pyrido [3,4-B] indole derivatives and methods of use |
| US9187471B2 (en) | 2010-02-19 | 2015-11-17 | Medivation Technologies, Inc. | Pyrido [4,3-b] indole and pyrido [3,4-b] indole derivatives and methods of use |
| WO2011103448A1 (en) | 2010-02-19 | 2011-08-25 | Medivation Technologies, Inc. | Methods and compositions for treating psychotic disorders using antipsychotic combination therapy |
| WO2012112965A1 (en) | 2011-02-18 | 2012-08-23 | Medivation Technologies, Inc. | Compounds and methods of treating diabetes |
| CA2829045A1 (en) | 2011-02-18 | 2012-08-23 | Medivation Technologies, Inc. | Compounds and methods for treatment of hypertension |
| US20140155384A1 (en) | 2011-02-18 | 2014-06-05 | Medivation Technologies, Inc. | Compounds and methods of treating diabetes |
| WO2012112964A2 (en) | 2011-02-18 | 2012-08-23 | Medivation Technologies, Inc. | PYRIDO[4,3-b]INDOLE AND PYRIDO[3,4-b]INDOLE DERIVATIVES AND METHODS OF USE |
| WO2014031170A1 (en) | 2012-08-22 | 2014-02-27 | Medivation Technologies, Inc. | Pyrido[4,3-b]indole and pyrido[3,4-b]indole derivatives and methods of use |
| WO2014031167A1 (en) | 2012-08-22 | 2014-02-27 | Medivation Technologies, Inc. | Compounds and methods for treatment of hypertension |
-
2010
- 2010-04-29 WO PCT/US2010/033055 patent/WO2011019417A1/en not_active Ceased
- 2010-04-29 BR BRPI1006608-0A patent/BRPI1006608A2/pt not_active IP Right Cessation
- 2010-04-29 CN CN201080029084.1A patent/CN102480956B/zh not_active Expired - Fee Related
- 2010-04-29 EP EP10808471.6A patent/EP2424366B1/en not_active Not-in-force
- 2010-04-29 CA CA2760516A patent/CA2760516A1/en not_active Abandoned
- 2010-04-29 AU AU2010282990A patent/AU2010282990B2/en not_active Ceased
- 2010-04-29 JP JP2012508752A patent/JP5827943B2/ja not_active Expired - Fee Related
- 2010-04-29 US US13/318,124 patent/US8741919B2/en not_active Expired - Fee Related
-
2013
- 2013-03-08 US US13/791,862 patent/US8927571B2/en not_active Expired - Fee Related